Come up with a name for your new list and we'll add to it:
Scancell raised a round of funding on , . Investors include
Oxford Capital Partners.
Scancell is developing products that stimulate the immune system to treat or prevent cancer. The Company has four therapeutic antibodies in development and a pipeline of improved cancer vaccines based…